Normative Database and Test-Retest Reliability for BrainCheck Assessments
NCT ID: NCT05497427
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1300 participants
OBSERVATIONAL
2022-10-10
2025-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
NCT04800588
Cognitive Screening and Cognitive Training in Seniors
NCT02588209
Smart Cupboard-based System for Memory Assessment in Alzheimer's Patients
NCT05202197
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562
Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
NCT03672279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
With the decline in cognition occurring at a quicker rate at older ages, this study aims to collect additional data from healthy older adults to better capture the normative distribution among these age groups from existing and new assessments.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normative
BrainCheck assessment values from participants that have indications of healthy cognition at the time of testing ( a SLUMS result considered 'normal', more than 4 hours of sleep the night before, not having consumed alcohol or drugs within the last 6 hours, or not have participated in high capacity and strenuous physical activity within the last hour.)
BrainCheck Assessment
A computerized neurocognitive test administered via an electronic device, such as a phone, tablet or computer, that contains several assessments that will aid in establishing an individuals cognitive performance
Test-Retest
Comparing BrainCheck assessment values between an initial visit test and a follow-up visit test 7-14 days later within subjects.
BrainCheck Assessment
A computerized neurocognitive test administered via an electronic device, such as a phone, tablet or computer, that contains several assessments that will aid in establishing an individuals cognitive performance
Per Protocol
BrainCheck assessment values from participants that completed all procedures with no protocol deviations
BrainCheck Assessment
A computerized neurocognitive test administered via an electronic device, such as a phone, tablet or computer, that contains several assessments that will aid in establishing an individuals cognitive performance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BrainCheck Assessment
A computerized neurocognitive test administered via an electronic device, such as a phone, tablet or computer, that contains several assessments that will aid in establishing an individuals cognitive performance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to comply with study requirements and activities
Exclusion Criteria
* Neurosurgery within the last month
* Experienced a stroke
* Self reported neurological condition (including mild neuropsychological impairment, dementia, Parkinson's disease, amyotrophic lateral sclerosis, Multiple sclerosis, or long-covid)
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BrainCheck, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BrainCheck
Palo Alto, California, United States
Maplewood Senior Living
Multiple Locations, Connecticut, United States
BrainCheck
Austin, Texas, United States
BrainCheck
Houston, Texas, United States
BrainCheck
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
More information on the study and signup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00064230
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.